Tag: amyotrophic lateral sclerosis

Brain’s immune system is key to recovery from motor neuron degeneration...

Researchers have engineered mice in which the damage caused by a mutant human TDP-43 protein could be reversed by one type of brain immune...

FDA approves drug to treat ALS

The US Food and Drug Administration has approved Radicava (edaravone) to treat patients with amyotrophic lateral sclerosis (ALS). Radicava is an intravenous infusion given by...

BrainStorm Cell Therapeutics’ trial of NurOwn in ALS deemed safe by...

The Data Safety and Monitoring Board has conducted its second pre-planned safety review of the phase 2 clinical trial of NurOwn in amyotrophic lateral...

Presymptomatic ALS patients consume more calories but have lower BMIs than...

Presymptomatic patients with amyotrophic lateral sclerosis (ALS) consumed more daily calories but had lower body-mass index (BMI) than those individuals without ALS, reports a...

Clinical trial moves stem cell therapy for ALS patients one step...

Stem cells are a safe therapy for patients with amyotrophic lateral sclerosis (ALS), according to the results of a recently completed phase 1 clinical trial.

NurOwn demonstrates a statistically significant effect in ALS patients

BrainStorm Cell Therapeutics presented results from its phase 2a study of NurOwn in amyotrophic lateral sclerosis (ALS) at a poster session at the American Academy of Neurology annual meeting, in Washington, DC, USA.

The ALS Association to collaborate with GlaxoSmithKline on new ALS clinical...

The ALS Association, Harvard Stem Cell Institute, and Massachusetts General Hospital Neurological Clinical Research Institute have announced that they are collaborating with GlaxoSmithKline on a clinical trial to evaluate the potential of an anti-epileptic drug in ALS patients.

ALS Association triples research spending following ice bucket donations

The ALS Association Board of Trustees has developed a long-term strategy for leveraging the Ice Bucket Challenge donations it has received to advance its integrated mission of leading the fight to treat and cure ALS through global research, care services and public policy.